feed,title,long_url,short_url
Benzinga,Novartis' Malaria Treatment Candidate To Move Forward With Phase 3 Development Next Year,https://benzinga.com/general/biotech/22/11/29839378/novartis-malaria-treatment-candidate-to-move-forward-with-phase-3-development-next-year,https://bit.ly/3tXzCLH
Benzinga,$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today,https://benzinga.com/news/earnings/22/11/29841065/100-invested-in-this-stock-10-years-ago-would-be-worth-500-today,https://bit.ly/3gvFybC
Benzinga,$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today,https://benzinga.com/news/earnings/22/11/29841060/100-invested-in-this-stock-5-years-ago-would-be-worth-200-today,https://bit.ly/3V29PxP
